Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.

Mimoto R, Nihira NT, Hirooka S, Takeyama H, Yoshida K
Cancer Lett. 2017 Jan 1;384:27-38. doi: 10.1016/j.canlet.2016.10.015. Epub 2016 Oct 13. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.